中国细胞疗法监管和政策的发展
Tao Na1,2,3,4, Kehua Zhang1,2,3,4, Zhaohui Wu5
1National Institutes for Food and Drug Control, Beijing, China.
Advances in experimental medicine and biology
|October 24, 2025
概括
中国中国中国中国.
科学领域:
- 再生医学是一种再生医学.
- 细胞治疗产品开发 细胞治疗产品开发
背景情况:
- 细胞疗法产品 (CTP) 是中国再生医学领域快速发展的一个领域.
- 越来越多的CTP新药应用突显了它们的治疗潜力.
- 证券交易平台的复杂性带来了重大的监管障碍.
研究的目的:
- 检查中国对细胞治疗产品实施的监管策略.
- 了解监管框架如何适应CTP的复杂性.
- 评估监管改进对CTP临床翻译的影响.
主要方法:
- 对中国细胞疗法产品监管框架演变的分析.
- 监管机构对质量评估改进的审查.
- 评估行业监管机构的沟通和合作倡议.
主要成果:
- 中国的监管机构正在积极完善框架,并加强对CTP的质量评估.
- 监管机构和行业之间的积极参与和协作是显而易见的.
- 这些努力成功地解决了CTP多样性带来的监管挑战.
结论:
- 持续的监管调整和强有力的质量评估对于CTP发展至关重要.
- 开放的沟通和协作促进了CTP创新的支持环境.
- 中国的监管方法促进了细胞治疗产品的健康临床转化.
相关概念视频
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cell Lines
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...


